I’ve heard people argue that metformin is bad for you because it raises lactate levels.
Intense exercise also raises lactate.
In fact, newer research suggests certain byproducts of lactate formed during intense exercise contribute to the metabolic benefits of the exercise.
The same byproducts of lactate are formed after taking metformin.
Link to the full study:
Paper · EMBO Mol Med · 2026The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patientsRandomized clinical trials have highlighted the importance of weight control and exercise in improving cancer outcomes, yet the molecular mediators of these benefits remain poorly understood. Recent studies in Type 2 diabetic patients reported that the insulin-sensitizing drug, metformin, exerts its anorexigenic and anti-obesogenic effects through elevation of N-lactoyl-phenylalanine (Lac-Phe), a metabolite also…link.springer.comLinks to media coverage on the study:
- Metformin elevates anti-obesogenic metabolite Lac-Phe in prostate cancer | Urology Times (urologytimes.com)
- Diabetes drug metformin echo benefits (medicalxpress.com)
- Metformin boosts an exercise-linked metabolite and may help control weight in prostate… (News-Medical)
Quoted (from #2):
“Lac‑Phe is produced when the body is under metabolic demand. It forms when lactate—a substance that accumulates during exertion—combines with phenylalanine, a basic building block of protein. Scientists first took notice of Lac‑Phe because its levels spike after intense exercise, coinciding with shifts in energy use and appetite regulation.
In preclinical and early human studies, higher Lac‑Phe levels have been associated with reduced appetite and improved weight control—two effects commonly linked to regular physical activity.
Lac-Phe does not rise only with exercise. Scientists observed elevated Lac-Phe levels in people taking metformin, even in the absence of physical activity.”
Quoted (from #3):
“Evidence from clinical studies suggests that weight control and exercise improve cancer outcomes, yet the mechanisms underlying these effects remain poorly understood. Metformin, a widely prescribed medication that improves insulin sensitivity, has been linked to increased Lac-Phe levels, which may influence appetite and weight regulation. These observations suggest that metformin may mimic some of the exercise-related metabolic benefits in cancer patients.”


